Implantable Medical Devices Market Size By Product (Cardiovascular {Implantable Cardiac Defibrillators [ICDs], Stents, Pacemaker, Implantable Cardiac Monitors [ICM], Ventricular Assist Devices, Cardiac Resynchronization Therapy Devices [CRT]}, Orthopedic {Joint Reconstruction, Spinal Devices, Trauma Fixation Devices}, Ophthalmology {Intraocular Lenses and Glaucoma Implants}, Plastic Surgery {Breast Implants, Gluteal Implants}, Neurology {Deep Brain Stimulators}, Dental {Dental Implants, Dental Crowns and Abutment}), By Type (Diagnostic, Treatment), By Nature of Device (Active, Static/Non-active/Passive), By End-use (Hospitals, Multi-specialty Centres, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jan 2020  |  Report ID: GMI4483  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Implantable Medical Devices Market Trends

Implantable medical devices (IMDs) are partly or fully introduced medical devices in the human body for either treatment or monitoring of diseases. These devices are either surgically or medically implanted and are made of synthetic material. These medical devices can be used to replace missing or damaged body parts such as knees or hips or to monitor various body functions such as heart rate to provide support to tissues and organs and restore overall functioning of the body.

Implantable Medical Devices Market

Get more details on this report - Request Free Sample PDF

Some implants are used to provide structural support such as stents or dental implants while others interact with the body by sending out impulse or electrical waves in order to align with body’s rhythm. With increasing incidence of organ failures due to chronic disorders and accidents, the implantable medical devices market demand will increase substantially in the foreseeable future.

Since first pacemaker implant in 1958, the implantable medical devices industry has made significant developments. From facing serious challenges such as material quality, battery durability, system delivery, functionality and wireless communication, the industry has advanced with adoption of microelectronics, biocompatible materials and sensor technology.

The history of implantable medical device reflects the development of power source, electronic technology, and related fields. Following the progress of the implantable medical devices in 1960 with the help of Greatbatch and co-workers, the first successful human transplant was done, wherein pacemakers were implanted successfully in about ten patients. Later major medical device companies such as Medtronic started collaborating with researchers to make progress in implantable devices to the next level.

Immense advancements have been made in devices such as deep brain stimulators, hip implants, breast implants, blood pressure sensors and several others to promote the proper functioning of the organs. In future, the industry will foresee significant breakthroughs, especially in active IMDs by incorporation of microelectro-mechanical systems and miniaturization that will ensure better treatment and outcome of fatal chronic disorders and disability.

Implantable Medical Devices Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 90.6 Billion (USD)
Historical Data for: 2014 to 2017 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 6.3% 2025 Value Projection: 138.8 Billion (USD)
Pages: 250 Tables, Charts & Figures: 545
Geographies covered (19): U.S., Canada, Germany, UK, France, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE
Segments covered: Product, Type, Nature of Device, End-use and Region
Companies covered (20): Medtronic PLC, Zimmer Biomet, Allergan PLC, Teva Pharmaceutical Industries, Stryker Corporation, Smith & Nephew, Boston Scientific Corporation, Abbott Laboratories, Alcon Laboratories, Bausch & Lomb, Getinge AB, POLYTECH Health & Aesthetics, Nuvectra Corporation, Demant, Intersect ENT, Cochlear, W.L. Gore & Associates, Henry Schein, Biotronik, Johnson & Johnson
Growth Drivers:
  • Increasing incidence of chronic diseases across the globe
  • Scarcity of organ donors
  • Technological advancements in developed nations
  • Rising government funding for implantable medical devices in developed countries
  • Increasing focus on development of microelectronics and implantable sensors
  • Growing adoption of biomaterials for better biocompatibility and outcomes
Pitfalls & Challenges:
  • High cost of devices
  • Stringent regulations for active implantable medical devices
  • Considerable rate of post-procedural complications
  • High number of recalls of implantable medical devices

Get more details on this report - Request Free Sample PDF

Increasing number of accidents and injuries will offer lucrative growth opportunity for the implantable medical device market

Every year numerous people are enhancing their life quality by undergoing surgical procedures involving implantation of medical devices. With an increase in age-related diseases, there has been a prolonged need of medical devices for better treatment of the chronic medical conditions.

Rising incidence of chronic disorders, organ failures and scarcity of organ donors worldwide will augment the market growth across forecast years. However, high cost associated with implantable medical devices and security and privacy concerns related to devices may hamper the market growth to a certain extent.

Orthopedic implant industry, a billion-dollar market, is set to progress rapidly in both developed and developing nations

Implantable Medical Devices Market Size By Product

Get more details on this report - Request Free Sample PDF

The market on the basis of product segment is categorized into cardiovascular, orthopaedic, ophthalmology, plastic surgery, neurology, dental and others. Orthopedic implantable medical devices market size was valued at over USD 32 billion in 2018 and will foresee robust growth. Orthopedic segment consists of various implantable devices such as trauma fixation devices, spinal devices, joint reconstruction and others. The industry is working constantly to improve clinical outcomes of implantable medical devices.

Rising prevalence of orthopedic disorders coupled with increasing geriatric population and road accidents will have significant impact on the overall market growth in the future years. Recently people are undergoing total hip and knee replacement surgeries due to rise in bone fractures and injuries. Growing prevalence of osteoporosis, osteoarthritis and sports injuries are further augmenting the market growth. Moreover, manufacturers are significantly investing in R&D to develop efficient devices, positively affecting the market growth.

High-tech monitoring devices reduces the dependency of patients on family and medical caregivers, thus boosting their adoption

By type segment the market is classified into therapeutic and diagnostic implantable devices. Diagnostic implantable medical device market is estimated to hold revenue size of around USD 700 million in 2018. High growth rate of diagnostic devices is attributed to increasing cases of chronic disorders such as cardiac disorders, obesity, diabetes due to sedentary lifestyle.

Implantable medical devices such as blood pressure sensors and implantable loop recorders help the physicians and patients to monitor their illness to get an early update. These devices are wireless and automated, and they evaluate patient’s tolerance to drug dosage used for treatment. Adoption of advanced technology benefits associated with monitoring implantable devices for generating high-quality results will drive the market growth in the future.

Demand for active implantable medical devices to surge owing to rising need to treat serious neurological conditions

Based on the nature of device, implantable medical devices market is bifurcated into active and static/non-active/passive implantable medical devices. Active implantable medical devices segment accounted for more than 23.5% industry share in 2018. Active implantable medical devices include wide range of products such as pacemakers, infusion pumps, ventricular assists systems and defibrillators. Increasing cases of diseases such as Parkinson’s disease, spasticity, and other neurological conditions will augment the market growth.

Commendable progress in treatment of paralysis patients using brain computer interface technology has been achieved with significant recovery of lost speech and mobility in patients. Furthermore, presence of advanced technology and rising prevalence of hypertension, diabetes mellitus and cardiac arrhythmia among others will further aid the market size over the forthcoming years.

In context to providing improved healthcare to patients, multi-specialty centers play a vital role in impelling the number of implantations

Based on end-use, implantable medical devices industry is segmented into hospitals, multi-speciality centres, ambulatory surgical centres, clinics and others. Multi-speciality centres will witness a robust 6.3% CAGR over the analysis period. Multi-speciality centres offer specialized treatment to medical conditions that require advanced skills and technology.

Better accessibility of implantable medical devices will foster the market growth. Speciality centres provide better medical service, less medical complications, lower long-term cost and better outcomes. Rising incidence of cardiovascular, orthopaedic, and other chronic disorders will also augment the growth of the multi-speciality centres in the forthcoming years.

Rapid adoption of state-of-the-art technology in implantable medical devices in North America will boost the regional growth

 Implantable Medical Devices Market By Region   

Get more details on this report - Request Free Sample PDF

Also, significant increase in mortality rate due to cardiovascular and neurological disorders has played a major role in demand for implantable medical devices in the U.S. Furthermore, high disposable income coupled with attractive reimbursement scenario will continue to offer lucrative market growth over the forthcoming years.

Adoption of sedentary lifestyle, rising geriatric population, huge investment in research and development activities have augmented Japan implantable medical device market growth. Elderly people are witnessing higher prevalence of osteoarthritis and orthopedic injuries requiring implantable orthopedic devices. In addition, presence of sophisticated medical facilities and rapid adoption of high-end technology will also boost the market growth in the country during the upcoming years.

Market leaders are focusing on product innovation to strengthen implantable medical device portfolio

Some of the key market players operating in the global implantable medical devices market share are Medtronic, Zimmer Biomet, Stryker, Johnson & Johnson and Abbott among other players. These market players are implementing various strategies such as new product launch, acquisitions and collaborations, in order to capitalize high revenue share.

Recent industry developments:

  • In October 2019, Medtronic received breakthrough device designation from FDA for fully implantable left ventricular assist device (LVAD) for patients with advanced heart failure. This designation will help the company to provide more effective treatment or diagnosis for life threatening disease, thereby expanding its business size. 
  • In January 2018, Zimmer Biomet announced FDA clearance of the Sidus Stem Free Shoulder System. The clearance helped the company in expanding its product portfolio, thus strengthening its market position in implantable medical devices industry.

Implantable medical devices Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

By Product

  • Cardiovascular        
    • Pacemaker
    • Implantable cardiac defibrillators (ICDs)
    • Cardiac Resynchronization Therapy (CRT)
    • Stents
    • Ventricular assist devices
    • Implantable cardiac monitors (ICM)
    • Others 
  • Orthopedic    
    • Joint Reconstruction
    • Trauma Fixation Devices
    • Spinal Devices
    • Others
  • Ophthalmology        
    • Intraocular Lenses and Glaucoma Implants
    • Others
  • Plastic surgery        
    • Breast Implants
    • Gluteal Implants
  • Neurology     
    • Deep Brain Stimulators
    • Others
  • Dental
    • Dental Implants
    • Dental Crowns and Abutment
    • Dental Brackets and Braces
    • Others
  • Others

By Type

  • Diagnostic
  • Therapeutic

By Nature of Device

  • Active
  • Passive/Non-active/Static

By End-use

  • Hospitals
  • Multi-specialty Centers
  • Ambulatory Surgical Centers
  • Clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE


Frequently Asked Questions (FAQ) :

The market size of implantable medical devices surpassed USD 90.5 billion in 2018.
The industry share of implantable medical devices is projected to expand at more than 6.3% CAGR to 2025.
Implantable medical devices (IMDs) are partly or fully introduced medical devices in the human body for either treatment or monitoring of diseases.
Diagnostic implantable medical device market is estimated to hold revenue size of around USD 700 million in 2018, says a GMI report.
Active implantable medical devices market segment accounted for more than 23.5% market share in 2018.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jan 2020
  • Pages: 250
  • Tables: 531
  • Charts / Figures: 14
  • Companies covered: 20
  • Countries covered: 19

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X